Short-term evaluation of combination corticosteroid+anti-VEGF treatment for persistent central-involved diabetic macular edema following anti-VEGF therapy in pseudophakic eyes (protocol U),
Role: Investigator,
Diabetic Retinopathy Clinical Research Network (DRCRnet),
(04/2017 - 04/2018)
Status: Completed
A phase II, multicenter, randomized, single-masked, sham injection-controlled exposure-response study of lampalizumab intravitreal injections administered every two weeks or every four weeks to patients with geographic atrophy,
Role: Investigator,
Genentech, Inc.,
(10/2016 - 10/2017)
Status: Completed